Literature DB >> 17901056

Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding.

Thomas Jank1, Torsten Giesemann, Klaus Aktories.   

Abstract

Recently the crystal structure of the catalytic domain of Clostridium difficile toxin B was solved ( Reinert, D. J., Jank, T., Aktories, K., and Schulz, G. E. (2005) J. Mol. Biol. 351, 973-981 ). On the basis of this structure, we studied the functional role of several amino acids located in the catalytic center of toxin B. Besides the (286)DXD(288) motif and Trp(102), which were shown to be necessary for Mn(2+) and UDP binding, respectively, we identified by alanine scanning Asp(270), Arg(273), Tyr(284), Asn(384), and Trp(520) as being important for enzyme activity. The amino acids Arg(455), Asp(461), Lys(463), and Glu(472) and residues of helix alpha17 (e.g. Glu(449)) of toxin B are essential for enzyme-protein substrate recognition. Introduction of helix alpha17 of toxin B into Clostridium sordellii lethal toxin inhibited modification of Ras subfamily proteins but enabled glucosylation of RhoA, indicating that helix alpha17 is involved in RhoA recognition by toxin B. The data allow the design of a model of the interaction of the glucosyltransferase domain of toxin B with its protein substrate RhoA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901056     DOI: 10.1074/jbc.M703138200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.

Authors:  Haiying Wang; Xingmin Sun; Yongrong Zhang; Shan Li; Kevin Chen; Lianfa Shi; Weijia Nie; Raj Kumar; Saul Tzipori; Jufang Wang; Tor Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

4.  Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins.

Authors:  Angela M Payne; Julie Zorman; Melanie Horton; Sheri Dubey; Jan ter Meulen; Kalpit A Vora
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

Review 5.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 6.  Clostridium difficile toxins: mediators of inflammation.

Authors:  Aimee Shen
Journal:  J Innate Immun       Date:  2012-01-10       Impact factor: 7.349

7.  Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.

Authors:  Joseph W Alvin; D Borden Lacy
Journal:  J Struct Biol       Date:  2017-04-19       Impact factor: 2.867

8.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

9.  Disruption of intrinsic motions as a mechanism for enzyme inhibition.

Authors:  Rebecca J Swett; G Andrés Cisneros; Andrew L Feig
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

10.  The molecular pathogenesis of Clostridium difficile-associated disease.

Authors:  David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.